ANI PHARMACEUTICALS INC Insider Trading for April 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANI PHARMACEUTICALS INC for April 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18 2019 | ANIP | ANI PHARMACEUTICAL ... | Schrepfer Robert W | SVP - New Bus Dev & ... | Payment of Exercise | F | 68.60 | 360 | 24,696 | 58,336 | 58.7 K to 58.3 K (-0.61 %) |
| Apr 18 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 68.60 | 1,692 | 116,071 | 232,589 | 234.3 K to 232.6 K (-0.72 %) |
| Apr 18 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 68.60 | 115 | 7,889 | 75,054 | 75.2 K to 75.1 K (-0.15 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 70.50 | 144 | 10,152 | 75,169 | 75.3 K to 75.2 K (-0.19 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 70.50 | 337 | 23,759 | 75,313 | 75.7 K to 75.3 K (-0.45 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | Schrepfer Robert W | SVP - New Bus Dev & ... | Payment of Exercise | F | 70.50 | 392 | 27,636 | 58,696 | 59.1 K to 58.7 K (-0.66 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | Schrepfer Robert W | SVP - New Bus Dev & ... | Payment of Exercise | F | 70.50 | 659 | 46,460 | 59,088 | 59.7 K to 59.1 K (-1.10 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | CAREY STEPHEN P. | Vice President and ... | Payment of Exercise | F | 70.50 | 612 | 43,146 | 25,450 | 26.1 K to 25.5 K (-2.35 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 70.50 | 2,115 | 149,108 | 234,281 | 236.4 K to 234.3 K (-0.89 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 70.50 | 3,282 | 231,381 | 236,396 | 239.7 K to 236.4 K (-1.37 %) |
| Apr 02 2019 | ANIP | ANI PHARMACEUTICAL ... | Schrepfer Robert W | SVP - New Bus Dev & ... | Payment of Exercise | F | 70.54 | 546 | 38,515 | 59,747 | 60.3 K to 59.7 K (-0.91 %) |
| Apr 02 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 70.54 | 2,678 | 188,906 | 239,678 | 242.4 K to 239.7 K (-1.10 %) |
| Apr 02 2019 | ANIP | ANI PHARMACEUTICAL ... | CAREY STEPHEN P. | Vice President and ... | Payment of Exercise | F | 70.54 | 507 | 35,764 | 26,062 | 26.6 K to 26.1 K (-1.91 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Walsh Patrick D | Director | Option Exercise | A | 66.39 | 2,409 | 159,934 | 2,409 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Walsh Patrick D | Director | Grant | A | 0.00 | 1,991 | 0 | 3,791 | 1.8 K to 3.8 K (+110.61 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | NASH DAVID | Director | Option Exercise | A | 66.39 | 2,409 | 159,934 | 2,409 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | NASH DAVID | Director | Grant | A | 0.00 | 1,991 | 0 | 3,791 | 1.8 K to 3.8 K (+110.61 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Option Exercise | A | 66.39 | 8,285 | 550,041 | 8,285 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Grant | A | 0.00 | 6,848 | 0 | 75,928 | 69.1 K to 75.9 K (+9.91 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | A | 66.39 | 45,106 | 2,994,587 | 45,106 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Grant | A | 0.00 | 37,280 | 0 | 242,356 | 205.1 K to 242.4 K (+18.18 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | CAREY STEPHEN P. | Vice President and ... | Option Exercise | A | 66.39 | 15,064 | 1,000,099 | 15,064 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | CAREY STEPHEN P. | Vice President and ... | Grant | A | 0.00 | 12,451 | 0 | 26,569 | 14.1 K to 26.6 K (+88.19 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | HAUGHEY THOMAS | Director | Option Exercise | A | 66.39 | 2,409 | 159,934 | 2,409 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | HAUGHEY THOMAS | Director | Grant | A | 0.00 | 1,991 | 0 | 3,791 | 1.8 K to 3.8 K (+110.61 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Brown Robert E. JR | Director | Option Exercise | A | 66.39 | 3,127 | 207,602 | 3,127 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Brown Robert E. JR | Director | Grant | A | 0.00 | 2,584 | 0 | 20,352 | 17.8 K to 20.4 K (+14.54 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Schrepfer Robert W | SVP - New Bus Dev & ... | Option Exercise | A | 66.39 | 15,064 | 1,000,099 | 15,064 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Schrepfer Robert W | SVP - New Bus Dev & ... | Grant | A | 0.00 | 12,451 | 0 | 60,293 | 47.8 K to 60.3 K (+26.03 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Penn Thomas A. | Director | Option Exercise | A | 66.39 | 2,409 | 159,934 | 2,409 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Penn Thomas A. | Director | Grant | A | 0.00 | 1,991 | 0 | 14,301 | 12.3 K to 14.3 K (+16.17 %) |